Zymeworks BC Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 73 rows in 2019. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2019-12-12: Reporting owner Polverino Anthony J.; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2019-11-08: Reporting owner O'Driscoll Kathryn; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2019-06-11: Reporting owner Mahony Susan; Form 3; Security Stock Option (Right to Buy); Transaction Holding.
- 2019-06-11: Reporting owner Mahony Susan; Form 3; Security Stock Option (Right to Buy); Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2019-12-12 | Polverino Anthony J. Officer (Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −27,500 82,500 owned after | $15.00 exercise price | 2019-12-13 | |
| 2019-11-08 | O'Driscoll Kathryn Officer (Chief People Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +100,000 100,000 owned after | $34.24 exercise price | 2019-11-08 | |
| 2019-06-11 holding as of filing | Mahony Susan Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $19.20 exercise price | 2019-06-11 | ||
| 2019-06-11 holding as of filing | Mahony Susan Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $19.20 exercise price | 2019-06-11 | ||
| 2019-06-11 holding as of filing | Cox Troy Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $19.20 exercise price | 2019-06-11 | ||
| 2019-06-11 holding as of filing | Cox Troy Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $19.20 exercise price | 2019-06-11 | ||
| 2019-05-06 | Poon David Kai Yuen Officer (See Remarks) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −800 3,390 owned after | $3.53 exercise price | 2019-05-08 | |
| 2019-05-06 | Klompas Neil A Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,704 0 owned after | $2.66 exercise price | 2019-05-08 | |
| 2019-05-06 | Klompas Neil A Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −8,380 0 owned after | $3.53 exercise price | 2019-05-08 | |
| 2019-05-06 | Sacks Natalie Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $19.11 exercise price | 2019-05-08 | |
| 2019-05-06 | Hillan Kenneth J. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $19.11 exercise price | 2019-05-08 | |
| 2019-05-06 | Zoth Lota S. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $19.11 exercise price | 2019-05-08 | |
| 2019-05-06 | RENTON HOLLINGS Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $19.11 exercise price | 2019-05-08 | |
| 2019-05-06 | Bedford Nick Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $19.11 exercise price | 2019-05-08 | |
| 2019-03-27 | Klompas Neil A Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $15.23 exercise price | 2019-03-28 | |
| 2019-01-08 | HAUSMAN DIANA Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +75,000 75,000 owned after | $15.53 exercise price | 2019-01-10 | |
| 2019-01-08 | Klompas Neil A Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +90,000 90,000 owned after | $15.53 exercise price | 2019-01-10 | |
| 2019-01-08 | Tehrani Ali Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +235,000 235,000 owned after | $15.53 exercise price | 2019-01-10 | |
| 2019-01-08 | Polverino Anthony J. Officer (Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +75,000 75,000 owned after | $15.53 exercise price | 2019-01-10 | |
| 2019-01-08 | Poon David Kai Yuen Officer (See Remarks) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 25,000 owned after | $15.53 exercise price | 2019-01-10 | |
| 2019-01-02 holding as of filing | Sacks Natalie Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $6.80 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Sacks Natalie Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $6.80 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Sacks Natalie Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $17.20 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Hillan Kenneth J. Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $22.60 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Hillan Kenneth J. Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $22.60 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Hillan Kenneth J. Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $9.82 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Hillan Kenneth J. Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $17.20 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Zoth Lota S. Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $22.60 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Zoth Lota S. Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $22.60 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Zoth Lota S. Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $9.82 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Zoth Lota S. Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $17.20 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | RENTON HOLLINGS Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $22.60 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | RENTON HOLLINGS Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $22.60 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | RENTON HOLLINGS Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $9.82 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | RENTON HOLLINGS Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $17.20 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Bedford Nick Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $4.75 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Bedford Nick Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $14.44 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Bedford Nick Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $22.60 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Bedford Nick Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $22.60 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Bedford Nick Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $9.82 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Bedford Nick Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $17.20 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Poon David Kai Yuen Officer (See Remarks) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $4.75 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Poon David Kai Yuen Officer (See Remarks) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $5.37 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Poon David Kai Yuen Officer (See Remarks) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $7.26 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Poon David Kai Yuen Officer (See Remarks) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $11.60 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Poon David Kai Yuen Officer (See Remarks) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $14.44 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Poon David Kai Yuen Officer (See Remarks) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $12.10 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Poon David Kai Yuen Officer (See Remarks) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $22.60 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Poon David Kai Yuen Officer (See Remarks) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $13.21 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Poon David Kai Yuen Officer (See Remarks) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $15.59 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Polverino Anthony J. Officer (Chief Scientific Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $15.00 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | HAUSMAN DIANA Officer (Chief Medical Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $20.74 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | HAUSMAN DIANA Officer (Chief Medical Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $22.60 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | HAUSMAN DIANA Officer (Chief Medical Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $9.82 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | HAUSMAN DIANA Officer (Chief Medical Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $11.84 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Klompas Neil A Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $3.58 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Klompas Neil A Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $4.75 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Klompas Neil A Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $5.37 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Klompas Neil A Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $7.26 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Klompas Neil A Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $11.60 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Klompas Neil A Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $14.44 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Klompas Neil A Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $12.10 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Klompas Neil A Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $22.60 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Klompas Neil A Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $9.82 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Klompas Neil A Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $11.84 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Tehrani Ali Director, Officer (Chief Executive Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $5.37 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Tehrani Ali Director, Officer (Chief Executive Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $7.26 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Tehrani Ali Director, Officer (Chief Executive Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $11.60 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Tehrani Ali Director, Officer (Chief Executive Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $14.44 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Tehrani Ali Director, Officer (Chief Executive Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $12.10 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Tehrani Ali Director, Officer (Chief Executive Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $22.60 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Tehrani Ali Director, Officer (Chief Executive Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $9.82 exercise price | 2019-01-02 | ||
| 2019-01-02 holding as of filing | Tehrani Ali Director, Officer (Chief Executive Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $11.84 exercise price | 2019-01-02 |